Skip to main content

Quantoom Biosciences is growing in France with brand-new facilities for its DNA and enzymes activity located in Evry (Région Île-de-France)

Brussels (Belgium) – March 2, 2023 Quantoom Biosciences S.A. (“Quantoom”), a Belgian biotech with the mission to reinvent mRNA production announces today the opening of a brand-new facility in Évry-Courcouronnes (France). Following the SynHelix acquisition in 2021, Quantoom already had infrastructures in France, part of the Genopole campus, but these…

Read More

ABSCINT and the VUB announce a Notice of Allowance for their U.S. Patent covering diagnostic applications of its single-domain antibody labelled with radioisotopes for PET/CT imaging of HER2 cancer lesions

  Brussels, Liège, February 20, 2023. Vrije Universiteit Brussel (VUB) and its spin-off ABSCINT announce today that the United States Patent and Trademark Office (“USPTO”) has provided a Notice of Allowance for patent application No. 16/827,032, entitled “Radio-labelled antibody fragments for use in the prognosis and diagnosis of cancer as well as for the…

Read More

La Belgique renforce sa position stratégique dans le secteur pharmaceutique grâce à un entrepôt ultramoderne

La Belgique renforce sa position stratégique dans le secteur pharmaceutique grâce à un entrepôt ultramoderne MG Real Estate, Yusen Logistics Benelux et GSK posent le premier pilier d’un hub logistique de soins de santé avec traitement automatisé des commandes Gembloux, 20 décembre 2022 – MG Real Estate, Yusen Logistics et…

Read More